Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal Children’s Hospital Melbourne and a Professorial Research Fellow at the University of Melbourne. Andrew is the Co-Chair of Melbourne Children’s Global Health. He is a Fellow of the Australian Academy of Health and Medical Sciences.
Andrew did the majority of his medical training at The Royal Children’s Hospital, Melbourne. Andrew moved to Suva, Fiji, in 2005 where he conducted research towards his PhD (University of Melbourne). Subsequently, he completed his subspecialty training in paediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, Canada, before returning to Melbourne in 2010.
Andrew’s research focuses on tropical diseases, particularly scabies, Strep A and rheumatic heart disease. He is the Director of the World Scabies Program, recipient of the Macquarie 50th Anniversary Award, and Director of the World Health Organisation Collaborating Centre on Scabies Control. Andrew is Co-Director of the Australian Strep A Vaccine Initiative, Co-Chair of the Strep A Vaccine Global Consortium, and President of the Lancefield International Society for Streptococci and Streptococcal Diseases.
Andrew has won several awards including the inaugural Jian Zhou Medal awarded by the Australian Academy of Health and Medical Sciences in 2020, the Bailey K Ashford Medal awarded by the American Society of Tropical Medicine and Hygiene in 2020, and the Sir Gustav Nossal Medal for Global Health awarded by the Australian Academy of Science in 2024.
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal...
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal Children’s Hospital Melbourne and a Professorial Research Fellow at the University of Melbourne. Andrew is the Co-Chair of Melbourne Children’s Global Health. He is a Fellow of the Australian Academy of Health and Medical Sciences.
Andrew did the majority of his medical training at The Royal Children’s Hospital, Melbourne. Andrew moved to Suva, Fiji, in 2005 where he conducted research towards his PhD (University of Melbourne). Subsequently, he completed his subspecialty training in paediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, Canada, before returning to Melbourne in 2010.
Andrew’s research focuses on tropical diseases, particularly scabies, Strep A and rheumatic heart disease. He is the Director of the World Scabies Program, recipient of the Macquarie 50th Anniversary Award, and Director of the World Health Organisation Collaborating Centre on Scabies Control. Andrew is Co-Director of the Australian Strep A Vaccine Initiative, Co-Chair of the Strep A Vaccine Global Consortium, and President of the Lancefield International Society for Streptococci and Streptococcal Diseases.
Andrew has won several awards including the inaugural Jian Zhou Medal awarded by the Australian Academy of Health and Medical Sciences in 2020, the Bailey K Ashford Medal awarded by the American Society of Tropical Medicine and Hygiene in 2020, and the Sir Gustav Nossal Medal for Global Health awarded by the Australian Academy of Science in 2024.
Top Publications
Romani, L, Whitfeld, MJ, Koroivueta, J, Kama, M, Wand, H, Tikoduadua, L, Tuicakau, M, Koroi, A, Andrews, RM, Kaldor, JM, et al.
Mass Drug Administration for Scabies - 2 Years of Follow-up..
N Engl J Med
381(2)
:
186 -187
2019
view publication
Engelman, D, Cantey, PT, Marks, M, Solomon, AW, Chang, AY, Chosidow, O, Enbiale, W, Engels, D, Hay, RJ, Hendrickx, D, et al.
The public health control of scabies: priorities for research and action..
Lancet
394(10192)
:
81 -92
2019
view publication
Wong, N, Crawford, N, Oliver, J, McMinn, A, Ching, N, Baker, C, Smeesters, P, Daley, A, Steer, A.
A Cluster of Pediatric Invasive Group A Streptococcus Disease in Melbourne, Australia, Coinciding with a High-Burden Influenza Season.
Journal of Pediatric Infectious Diseases
14(04)
:
213 -218
2019
view publication
Osowicki, J, Azzopardi, KI, Baker, C, Waddington, CS, Pandey, M, Schuster, T, Grobler, A, Cheng, AC, Pollard, AJ, McCarthy, JS, et al.
Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study..
Vaccine
37(26)
:
3485 -3494
2019
view publication
Weil, GJ, Bogus, J, Christian, M, Dubray, C, Djuardi, Y, Fischer, PU, Goss, CW, Hardy, M, Jambulingam, P, King, CL, et al.
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study..
PLoS Med
16(6)
:
e1002839
2019
view publication